HealthDay - THURSDAY, July 2 (HealthDay News) -- Multaq (dronedarone) tablets have been approved by the U.S. Food and Drug Administration to promote a normal heart rhythm in people with atrial fibrillation or atrial flutter. These conditions cause the heart to beat too quickly and can prevent it from pumping blood correctly.

Name

Email

Website

Comment

smaller | bigger

Subscribe via email (Registered users only)

Write the displayed characters

Add Comment